Post Profile

Samsung Bioepis seeks Europe approval for its Herceptin copy

SEOUL (Reuters) - Biosimilars maker Samsung Bioepis, part of South Korea's top conglomerate Samsung Group [SAGR.UL], said on Tuesday it is seeking regulatory approval in Europe to sell its copy of Roche's breast cancer drug Hercepti...
read more


Related Posts

Roche's Breast Cancer Drug Perjeta Receives Green Light From EU

Health : Medical News Today

Today, Roche declared that the European Union gave a positive recommendation for the use of Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and docetaxel in patients with HER2-positive metastatic or location specifi...

India Partly Revokes Roche Patents For Herceptin Breast Cancer Drug

Medical / Pharmaceutical : Pharmalot

Once again, the Indian government has decided to revoke patents on a medicine sold by a global drugmaker. The latest episode involves patents for the Herceptin breast cancer treatment by Roche, which earlier this year agreed to lowe...

AstraZeneca pulls cancer drug application in Europe

Health : Reuters: Health

LONDON (Reuters) - AstraZeneca has pulled an application seeking European approval to sell its experimental cancer drug cediranib in combination with chemotherapy to treat ovarian cancer because of late-stage questions raised by reg...

Roche To Submit Breast Cancer Drug Pertuzumab In USA And Europe Later This Year

Health : Medical News Today

Roche Holding announced it will submit its breast cancer drug Pertuzumab towards the end of 2011 for approval in the USA and Europe after Genentech (a Roche company) said its Phase III clinical evaluation of the Pertuzumab and trast...

Samsung Affiliate Seeks European Approval for Herceptin Copy

Technology : Tech -

Samsung Group’s biologic drug-development affiliate submitted a near-replica of blockbuster breast cancer drug Herceptin for regulatory approval in Europe.


Copyright © 2016 Regator, LLC